Circulating tumor DNA to predict timing of relapse in mantle cell lymphoma.

被引：3
|
作者：
Roschewski, Mark J.
Melani, Christopher Joseph
Pittaluga, Stefania
Dunleavy, Kieron
Saba, Nakhle S.
Grant, Cliona
Aaron, Joan
Jacob, Allison
Yusko, Erik
Steinberg, Seth M.
Jaffe, Elaine S.
Wiestner, Adrian
Wilson, Wyndham Hopkins
机构：
[1] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, Bethesda, MD 20892 USA
[2] NCI, Ctr Canc Res, Bethesda, MD 20892 USA
[3] Ctr Canc Res, Div Canc Treatment & Diag, Bethesda, MD USA
[4] Tulane Univ Hlth Sci Ctr, New Orleans, LA USA
[5] St James Hosp, Dublin, Ireland
[6] NCI, Bethesda, MD 20892 USA
[7] Adapt Biotechnol, Seattle, WA USA
[8] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.7576
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7576
引用
收藏
页数：1
相关论文
共 50 条
  • [31] CD5 negative mantle cell lymphoma.
    Liu, Z
    Dong, H
    Gorczyca, W
    Tsang, P
    Cohen, P
    Stephenson, C
    Berger, C
    Wu, CD
    Weisberger, J
    BLOOD, 2001, 98 (11) : 126A - 126A
  • [32] Outcomes of autologous and allogeneic BMT for mantle cell lymphoma.
    Kasamon, YL
    Jones, RJ
    Diehl, LF
    Nayer, H
    Borowitz, MJ
    Garrett-Mayer, E
    Ambinder, RF
    Abrams, RA
    Zhang, Z
    Flinn, IW
    BLOOD, 2004, 104 (11) : 257A - 257A
  • [33] Validation of the Mantle Cell Lymphoma Prognostic Index (MIPI): A Valuable Tool for Risk Stratification in Mantle Cell Lymphoma.
    Smith, Stephen Douglas
    Hsi, Eric D.
    Bolwell, Brian J.
    Maggiotto, Amanda
    Effinger, Meagan
    Sweetenham, John William
    BLOOD, 2009, 114 (22) : 1058 - 1059
  • [34] Circulating tumor DNA (ctDNA) in B-cell lymphoma
    Scherer, Florian
    Kurtz, David M.
    Newman, Aaron M.
    Stehr, Henning
    Craig, Alexander F. M.
    Esfahani, Mohammad S.
    Lovejoy, Alexander F.
    Chabon, Jacob J.
    Klass, Daniel M.
    Green, Michael R.
    Liu, Chih L.
    Zhou, Li
    Glover, Cynthia
    Visser, Brendan C.
    Poultsides, George A.
    Advani, Ranjana H.
    Maeda, Lauren S.
    Gupta, Neel K.
    Davis, R. Eric
    Levy, Ronald
    Ohgami, Robert S.
    Kunder, Christian A.
    Rossi, Davide
    Westin, Jason
    Diehn, Maximilian
    Alizadeh, Ash A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 16 - 17
  • [35] Drug-induced apoptosis in primary tumor cells from mantle-cell lymphoma.
    Marce, S
    Ferrer, A
    Villamor, N
    Bellosillo, B
    Bosch, F
    Lopez-Guillermo, A
    Campo, E
    Montserrat, E
    Colomer, D
    BLOOD, 2003, 102 (11) : 172B - 172B
  • [36] Lenalidomide Enhances Anti-Tumor Effect of γδ T Cells against Mantle Cell Lymphoma.
    Gaidarova, Svetlana
    Corral, Laura G.
    Gleizer, Emilia
    Young, David
    Brady, Helen
    Bennett, Brydon
    Lopez-Girona, Antonia
    BLOOD, 2008, 112 (11) : 906 - 906
  • [37] Biological prognostic factors predict early relapse and refractory disease in diffuse large B cell lymphoma.
    Barrans, SL
    Howard, ME
    O'Connor, SJM
    Turner, KR
    Morgan, GJ
    Owen, RG
    Jack, AS
    BLOOD, 2003, 102 (11) : 395A - 395A
  • [38] A Novel Machine-Learning Model to Predict Early Relapse in Mantle Cell Lymphoma (MCL)
    Cabirta Touzon, Alba
    Mosquera Orgueira, Adrian
    Navarro Garces, Victor
    Abrisqueta, Pau
    Salcedo Pereda, Rodrigo A.
    Aliste Santos, Carlos
    Canelo Vilaseca, Marta
    Gomez Rosa, Marina
    Lopez Garcia, Alberto
    Garcia, Tomas
    De la Cruz Vicente, Fatima
    Sancho, Juan-Manuel
    Rios Herranz, Eduardo
    Cordoba, Raul
    Serna, Angel
    Iacoboni, Gloria
    Jimenez, Moraima
    Carpio, Cecilia
    Garcia, Cristina
    Gallur, Laura
    Castellvi, Josep
    Bosch, Francesc
    Marin Niebla, Ana
    BLOOD, 2023, 142
  • [39] The impact of early stem cell transplantation on the prognosis of mantle cell lymphoma.
    Dreger, P
    Martin, S
    Kröger, N
    Kuse, R
    Sonnen, R
    Glass, B
    Parwaresch, R
    Kneba, M
    Schmitz, N
    Haas, R
    BLOOD, 1999, 94 (10) : 172A - 172A
  • [40] Dendritic cell-based therapy for the treatment of mantle cell lymphoma.
    Munger, CM
    Hentzen, A
    Vose, JM
    Bociek, RG
    Joshi, SS
    BLOOD, 2003, 102 (11) : 106A - 106A
12345